Helical tomotherapy for extramedullary hematopoiesis involving the pericardium in a patient with chronic myeloid leukemia

Jpn J Radiol. 2010 Jul;28(6):476-8. doi: 10.1007/s11604-010-0452-y. Epub 2010 Jul 27.

Abstract

Extramedullary hematopoiesis (EMH) refers to the development of foci of hematopoiesis outside its normal location in the bone marrow. This occurs normally during fetal development but is abnormal postpartum. The most common sites of EMH are the spleen and liver. The phenomenon occurs in a number of disease states, notably in myelofibrosis, thalassemia, immune thrombocytopenic purpura, sickle cell anemia, polycythemia vera, and myelodysplastic syndrome. Affected patients often develop symptoms related to the location of the EMH. Reported treatments include red blood cell transfusions, surgical excision, decompressive laminectomy in cases of cord compression, chemotherapy, and irradiation. Radiation therapy is highly effective for treating hematopoietic tissue because such tissues are extremely radiosensitive. Megavoltage helical tomotherapy is a technical advance in the delivery of radiation therapy, allowing more conformal and precise treatments. The present case report describes a patient with the diagnosis of atypical chronic myeloid leukemia and myelofibrosis who subsequently developed EMH of the pericardium with effusion and tamponade. By utilizing tomotherapy we were able to treat the pericardium while sparing much of the myocardium. The patient tolerated treatment well without acute adverse effects. His symptoms were alleviated, but he died approximately 1 year later.

Publication types

  • Case Reports

MeSH terms

  • Fatal Outcome
  • Heart Diseases / etiology
  • Heart Diseases / radiotherapy*
  • Hematopoiesis, Extramedullary / radiation effects*
  • Humans
  • Leukemia, Myeloid / complications*
  • Male
  • Middle Aged
  • Pericardium / radiation effects*
  • Tomography, Spiral Computed / methods*